ASX Announcement 18 November 2026 GSS not proceeding with Proposed Merger with Microba Life Sciences ? Genetic Signatures Limited (ASX: GSS) (GSS) has resolved not to proceed with the Proposed Merger with Microba Life Sciences Limited (ASX: MAP) (Microba) in light of Microba’s announcement that...
End of Proposed Merger with Microba Life Sciences
Filed with ASX · · 2 pages · English
Summary by 6ix AI
After extensive discussions and due diligence, the board of Genetic Signatures determined that the risks associated with proceeding were too great. The company will formally withdraw a related resolution from its upcoming annual general meeting and provide further updates regarding the impact of this decision.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Genetic Signatures Ltd. on 6ix
Story so far
Earlier from Genetic Signatures
- Trading Halt
- GSS - Panel Receives Application
- Postponement of AGM & Further Addendum to the Notice of AGM
- Notification regarding unquoted securities - GSS
- 3X Initial Directors Interest Notice
Later from Genetic Signatures
- MAP: Proposed Merger with GSS not proceeding
- Withdrawal of Resolution 4 - Addendum to Notice of AGM
- BCAL Position on GSS-MAP Merger
- Board Changes and Final Director's Interest Notice
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures